#' Example data for demonstrating \code{sbhm}
#' 
#' @name schools
#' @aliases merit plato
#' @docType data
#' @details \code{schools}: the 8 schools data used in the exposition of simple
#' hierarchical Gaussian models by Gelman et al.
#' \code{merit}: the MERIT-HF data described by Wedel and DeMets and provided by
#' Quan.
#' \code{plato}: the (approximate) PLATO data, inferred from Mahaffey et al.
#' 
#' @author Harry Southworth
#' @references
#' A. Gelman, J. B. Carlin, H. S. Stern, D. B. Dunson, A. Vehtari and D. B. Rubin,
#' Bayesian Data Analysis (Third Edition), CRC/Chapman & Hall, 2014
#' 
#' H. Wedel, D. DeMets, P. Deedwania, B. Fagerberg, S. Goldstein, S. Gottlieb, A. Hjalmarson,
#' J. Kjekshus, F. Waagstein, J. Wikstrand and teh MERIT-HF Study Group, Challenges of
#' subgroup analyses in multinational clinical trials: experiences of the MERIT-HF trial,
#' American Heart Journal, 2001
#' 
#' H. Quan, M. Li, W. J. Shih, S. P. Ouyang, J. Chen, J. Zhang and P-L. Zhao, Empirical
#' shrinkage estimator for consistency assessment of treatment effects in multi-regional
#' clinical trials, Statistics in Medicine, 2012
#' 
#' K. W. Mahaffey, D. M. Wojdyla, K. Carroll, R. C. Becker, R. F. Storey, D. J. Angiolillo,
#' C. Held, C. P. Cannon, S. James, K. S. Pieper, J. Horrow, R. A. Harrington,
#' L. Wallentin on behalf of the PLATO  Investigators, Ticagrelor compared with
#' clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes
#' (PLATO) Trial, Circulation, 2011
#' @keywords data
NULL